Aldesleukin Terminated Phase 2 Trials for Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00005788Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome